VANCOUVER, Dec. 6, 2018 /CNW/ - 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE: TGIF) (OTCQX: TGIFF) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD products in Nevada, Colorado and California, is pleased to announce that it has met the eligibility requirements and has been accepted for trading on the OTCQX®, the OTC Markets' premier tier. The Company's common shares will continue to trade under the symbol TGIFF. The OTCQX® Best Market top tier is for established, high-growth and investor-focused companies wishing to gain added exposure in the United States.
Companies trading on the OTCQX® Best Market are distinguished by the integrity of their operations, have met certain financial asset tests and have demonstrated compliance with US securities laws and with disclosure requirements. OTCQX companies gain added exposure to US retail and institutional investors.
"Meeting the OTCQX® Best Market high financial and corporate governance standards was a significant milestone for the Company during our first year of trading", commented Mr. Brayden Sutton, President and CEO of 1933 Industries. He added, "As a US-focused issuer, we view graduating to the OTCQX® Best Market as an important step in our Company's growth. Not only does it provide greater visibility and profile for our Company as we continue to penetrate legal markets in the US, but it allows us to connect with an expanded and diverse network of potential investors".
The Company's common shares will continue to trade on the Company's primary exchange, the Canadian Securities Exchange, under the symbol TGIF. 1933 Industries was sponsored for OTCQX by Ortoli Rosenstadt LLP, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.
About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. Operating through three subsidiary companies, 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm supporting clients in security, intelligence and due diligence. The Company owns 91% of both Alternative Medicine Association and Infused MFG. and 100% of Spire Global Strategy.
Please visit our website at http://www.1933industries.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE 1933 Industries Inc.
For further information: Alexia Helgason, Corporate Communications Director, 604-674-4756 (ext. 1), email@example.com; Brayden Sutton, Director/President & CEO, 604-674-4756 (ext. 1)